New 2019 JSH guidelines and the risk of incident cardiovascular disease: The Suita Study

Ahmed Arafa1,2, Rena Kashima3,4, Yoshihiro Kokubo3

  • 1Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan. ahmed011172@med.bsu.edu.eg.

Insights

Hypertension significantly increases cardiovascular disease (CVD) risk. This study suggests starting CVD prevention at lower blood pressure (BP) levels than current 2019 Japanese Society of Hypertension guidelines recommend.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Hypertension is a primary risk factor for cardiovascular disease (CVD).
  • Current guidelines for hypertension diagnosis and management vary.
  • There is a need to identify optimal blood pressure (BP) targets for CVD prevention.

Purpose of the Study:

  • To investigate the association between blood pressure categories defined by the 2019 Japanese Society of Hypertension (JSH) guidelines and the risk of CVD, stroke, and coronary heart disease (CHD).
  • To determine if CVD preventive interventions should commence at lower BP thresholds than currently recommended.

Main Methods:

  • Utilized data from 7,643 participants (aged 30-84 years) from the Suita Study.
  • Followed participants for a median of 16.6 years (113,838 person-years).
  • Analyzed the association between BP levels (normal, high-normal, elevated, hypertension) and the incidence of CVD, stroke, and CHD.

Main Results:

  • Compared to normal BP (<120/80 mmHg), elevated BP (130-139/80-89 mmHg) and hypertension (≥140/90 mmHg) were significantly associated with increased risks of CVD, stroke, and CHD.
  • High-normal BP (120-129/<80 mmHg) was also associated with a higher risk of CVD and CHD.
  • A total of 690 CVD events occurred, including 411 strokes and 279 CHDs.

Conclusions:

  • The findings indicate that cardiovascular disease and its subtypes (stroke, CHD) risks are elevated even at BP levels below the hypertension threshold defined by the 2019 JSH guidelines.
  • CVD preventive strategies should be initiated earlier, targeting individuals with high-normal and elevated blood pressure.
  • Current JSH guidelines may not identify all individuals at high risk for CVD, suggesting a need for revised BP targets for prevention.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
274
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
46
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
29
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
43